LEADER 00634nam2 22002171i 450 
001 990002303810403321
035   $a000230381
035   $aFED01000230381
035   $a(Aleph)000230381FED01
035   $a000230381
100   $a20030801d--------km-y0itay50------ba
200 1 $aDrug utilization$egeographical differences and clinical implications. Concluding remarks. Oxford, 1979, v. 6, p. 169-170.
463  0$1001000221847
701  1$aLevy,$bM.$0345301
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002303810403321
959   $aFFABC
996   $aDrug utilization$9388182
997   $aUNINA
DB    $aING01